Reduced brain glutamate in patients with Parkinson's disease. - Wikidata - wikimedia - TriplyDB

Reduced brain glutamate in patients with Parkinson's disease.

Reduced brain glutamate in patients with Parkinson's disease.

http://www.wikidata.org/entity/Q40168580

about

Preclinical Magnetic Resonance Imaging and Spectroscopy Studies of Memory, Aging, and Cognitive Decline Magnetic Resonance Techniques Applied to the Diagnosis and Treatment of Parkinson's Disease Metabolic disturbances in diseases with neurological involvement Morphological and metabolic changes in the nigro-striatal pathway of synthetic proteasome inhibitor (PSI)-treated rats: a MRI and MRS study Neuroimaging biomarkers of neurodegenerative diseases and dementia Magnetic resonance spectroscopy to assess neuroinflammation and neuropathic pain.Magnetic resonance spectroscopy: an in vivo molecular imaging biomarker for Parkinson's disease?Ultra high-field (7tesla) magnetic resonance spectroscopy in Amyotrophic Lateral Sclerosis Metabolic Abnormalities in Abstinent Methamphetamine Dependent Subjects Relationship between transcranial magnetic stimulation measures of intracortical inhibition and spectroscopy measures of GABA and glutamate+glutamine.Brain metabolism differs in Alzheimer's disease and Parkinson's disease dementia.Cortical glutamate levels decrease in a non-human primate model of dopamine deficiency.Differences between conventional and nonconventional MRI techniques in Parkinson's disease.The effect of striatal dopamine depletion on striatal and cortical glutamate: A mini-review.Decreased immunoreactivities of neocortical AMPA receptor subunits correlate with motor disability in Lewy body dementias.Effects of electroacupuncture on metabolic changes in motor cortex and striatum of 6-hydroxydopamine-induced Parkinsonian rats.Correlations between plasma levels of amino acids and nonmotor symptoms in Parkinson's disease.Anterior cingulate integrity: executive and neuropsychiatric features in Parkinson's disease.An in vivo ultrahigh field 14.1 T (1) H-MRS study on 6-OHDA and α-synuclein-based rat models of Parkinson's disease: GABA as an early disease marker.Change in plasma levels of amino acid neurotransmitters and its correlation with clinical heterogeneity in early Parkinson's disease patients.Beyond Dopamine: GABA, Glutamate, and the Axial Symptoms of Parkinson Disease

P2860

Q26741139-564B2565-7512-44BF-834D-8305B0177614 Q26802087-78B325E9-34B2-4A24-881D-6D89F7036B5C Q26999015-BB9474BE-4C3D-4F70-9A01-D4D4566779F8 Q27314575-C1938E5B-151E-4AD2-9447-B82386ABEE47 Q27691820-5178A398-ECC1-47EA-8C7A-CD8E3A3EE6BE Q30624704-094EA42B-DF58-4B08-9884-463CE944B1E7 Q30858994-4BA8D9DA-0067-434A-8DDB-E675CEF70821 Q33675140-62001027-EB0B-4B23-AC81-0D1D720FFC16 Q33858507-751CF3CA-9150-4A11-B305-C158D4F77EFC Q36700350-83803049-F285-4FC4-9C24-CFC30A30CDF2 Q37010486-72DB900B-6A1F-4DB8-9645-A78F9744988D Q37733153-BC40B382-82DD-4572-A506-7069915548B2 Q38152514-424ECF64-A7B3-41AC-82E6-44ABE3EFEF59 Q38579616-56181901-8F3C-4AE5-9EB6-640B4A2B5109 Q48022171-62806E38-AC20-446B-A2B2-D6C99FC8D751 Q48029943-A11C4F67-37DF-49B2-8F75-845A306BBA4F Q48091966-32B00F8D-D975-471C-920A-5E4549ADF736 Q48418840-31C6A371-0FA1-4A1F-ACFB-B5A6972EC9A5 Q48468237-EA8FD76D-E8E4-483F-8607-59CF58B798B8 Q50249498-08E2235C-5FCA-4035-BD7F-CC04AFDAB249 Q57491499-F30D0F78-083C-4878-A41F-10D012C3336E

P2860

Reduced brain glutamate in patients with Parkinson's disease.

http://www.wikidata.org/entity/Q40168580

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

2008年论文

@zh

2008年论文

@zh-cn

name

Reduced brain glutamate in patients with Parkinson's disease.

@en

type

label

Reduced brain glutamate in patients with Parkinson's disease.

@en

prefLabel

Reduced brain glutamate in patients with Parkinson's disease.

@en

P1433

Q40168580-F4FF7B33-FA82-4B32-B107-811D22C9C227

P1476

Q40168580-90ABAECA-6607-4460-9DBB-FCA755F6687D

P2093

Q40168580-04F548F4-73C8-4E65-B775-647131AC4AA3

Q40168580-3989CAFE-130A-47F9-B2CB-35BDCD3EE780

Q40168580-701FC655-BD4F-43A5-B5D7-34FC5D742969

Q40168580-95E864B0-13A9-4A9C-8EB0-8D3BF16A1E3E

P2860

Q40168580-25B73413-EA6B-401C-91B6-34CE31FB6A82

Q40168580-5D341334-EA4D-4A6B-A8C0-A3D1E2D0F5F1

Q40168580-DAE0EA49-54CB-43DE-9535-F7960EFAFF05

P304

Q40168580-ED990EE7-EFEA-4608-8E33-E8B0217E859D

P31

Q40168580-DC12FBBE-9486-4F16-BF76-F0340CEB2485

P356

Q40168580-2C0838E3-8A29-4A91-A9F0-784A9343F5A8

P433

Q40168580-6B3D82E9-F6B5-4F8B-BE2D-9C5C61CDB459

P478

Q40168580-38D4CA3E-600D-4DF6-95CA-684A81AA6638

P577

Q40168580-86BD0F61-3F04-486E-BF05-177E9819336A

P698

Q40168580-832BB6FE-C01D-4FF3-9162-1066F90AAE8D

P921

Q40168580-4C697DE8-45F4-42D9-9919-6A48F54AFF73

P356

P1433

NMR in Biomedicine

P1476

Reduced brain glutamate in patients with Parkinson's disease.

@en

P2093

H Randall Griffith

http://www.w3.org/2001/XMLSchema#string

Jan A den Hollander

http://www.w3.org/2001/XMLSchema#string

Ozioma C Okonkwo

http://www.w3.org/2001/XMLSchema#string

Timothy O'Brien

http://www.w3.org/2001/XMLSchema#string

P2860

Magnetic resonance spectroscopy in AD.

1H MR spectroscopy in common dementias

Changes in putamen N-acetylaspartate and choline ratios in untreated and levodopa-treated Parkinson's disease: a proton magnetic resonance spectroscopy study.

P304

381-387

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/NBM.1203

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

21

http://www.w3.org/2001/XMLSchema#string

P577

2008-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17907264

http://www.w3.org/2001/XMLSchema#string

P921

Parkinson's disease